AU2001251507A1 - Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death - Google Patents

Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death

Info

Publication number
AU2001251507A1
AU2001251507A1 AU2001251507A AU5150701A AU2001251507A1 AU 2001251507 A1 AU2001251507 A1 AU 2001251507A1 AU 2001251507 A AU2001251507 A AU 2001251507A AU 5150701 A AU5150701 A AU 5150701A AU 2001251507 A1 AU2001251507 A1 AU 2001251507A1
Authority
AU
Australia
Prior art keywords
diagnosing
disorders
compositions
methods
cell death
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251507A
Inventor
Shawn Barney
Lawrence C. Katz
Donald C. Lo
Stuart D. Portbury
Kasturi Puranam
Mary Beth Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogent Neuroscience Inc
Original Assignee
Cogent Neuroscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cogent Neuroscience Inc filed Critical Cogent Neuroscience Inc
Publication of AU2001251507A1 publication Critical patent/AU2001251507A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001251507A 2000-04-11 2001-04-09 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death Abandoned AU2001251507A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54759600A 2000-04-11 2000-04-11
US09/547,596 2000-04-11
PCT/US2001/011655 WO2001076532A2 (en) 2000-04-11 2001-04-09 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death

Publications (1)

Publication Number Publication Date
AU2001251507A1 true AU2001251507A1 (en) 2001-10-23

Family

ID=24185296

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251507A Abandoned AU2001251507A1 (en) 2000-04-11 2001-04-09 Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death

Country Status (2)

Country Link
AU (1) AU2001251507A1 (en)
WO (1) WO2001076532A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19906096A1 (en) 1999-02-13 2000-08-17 Walter Sebald Protein with a heparin-binding epitope
ATE294859T1 (en) * 1999-09-17 2005-05-15 Univ Keio POLYPEPTIDE, HUMAN, WHICH INHIBITS THE DEATH OF NERVE CELLS
AU2003288434B2 (en) * 2002-12-06 2011-03-17 IRP Health Pty Ltd Peptides, antibodies thereto, and their use in the treatment of central nervous system damage
ES2536002T3 (en) 2003-05-21 2015-05-19 Andes Biotechnologies S.A. Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation in them
CN101470095B (en) * 2007-10-01 2012-05-23 中国人民解放军第三军医大学 Reagent kit for detecting plateau pneumochysis susceptibility based on mitochondria DNA G5351A mononucleotide polymorphism
US20140296139A1 (en) 2013-03-15 2014-10-02 The Regents Of The University Of California Mitochondrial-derived peptide mots3 regulates metabolism and cell survival
US11111271B2 (en) 2016-09-28 2021-09-07 Cohbar, Inc. Therapeutic peptides
CA3097341A1 (en) 2018-03-27 2019-10-03 Cohbar, Inc. Peptide-containing formulations
WO2021030749A1 (en) * 2019-08-15 2021-02-18 Cohbar, Inc. Therapeutic peptides
WO2021030794A1 (en) * 2019-08-15 2021-02-18 Cohbar, Inc. Therapeutic peptides
US20220306691A1 (en) * 2019-08-15 2022-09-29 Cohbar, Inc. Therapeutic peptides
WO2021030792A1 (en) * 2019-08-15 2021-02-18 Cohbar, Inc. Therapeutic peptides

Also Published As

Publication number Publication date
WO2001076532A2 (en) 2001-10-18
WO2001076532A9 (en) 2002-12-27
WO2001076532A8 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2085201A (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
WO2005046434A8 (en) Compositions and methods for diagnosing and treating mental disorders
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU8003800A (en) Methods and compositions for treating neurobehavioral disorders
AUPS323902A0 (en) Compositions and methods for treating gynaecological disorders
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
AU2001284865A1 (en) Methods for diagnosing and treating dysautonomia and other dysautonomic conditions
WO2001079164A3 (en) N-substituted dithiocarbamates for the treatment of biological disorders
AU2001251391A1 (en) Compositions and methods for promoting neural regeneration
AU2001251507A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
AU2001237939A1 (en) Methods for treating glaucoma
WO2003039490A9 (en) Compositions and methods for diagnosing and treating mental disorders
EP1670894B8 (en) Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
AU2001251508A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2001256998A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
ZA200203435B (en) Method and compositions for treating pulmonary diseases.
AU2001283199A1 (en) Methods and compositions for the diagnosis and treatment of brown adipose cell disorders
AU2002312314A1 (en) Compositions and methods for preventing neural tube disorders
AU2003214920A1 (en) Methods and compositions for treating hematological disorders
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases
AU2002316647A1 (en) Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death
AU2002217915A1 (en) Compositions and methods for diagnosing or treating psoriasis
AU6385200A (en) Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders